"Beautiful Clean Coal" Emissions: Republicans Approve, Dems Mute

Dr. Peter Carter

Elizabeth Woodworth

New Book Argues Crime Against Humanity

…a timely and important contribution to the debate regarding how criminal prosecutions…could be used to repress and deter climate damaging conduct at a large scale and on a lasting basis.”

— Reinhold Gallmetzer, Appeals Counsel, International Criminal Court

ATLANTA, GEORGIA, USA, February 1, 2018 /EINPresswire.com/ — In his State of the Union address Tuesday night, President Trump declared that “we have ended the war on beautiful, clean coal.”

Neither Trump, nor Joe Kennedy in his official Democratic response, said a word about climate change – although Americans who think global warming is real outnumber climate deniers by more than 5 to 1.

A timely appearance in this fog of unreality is a sound and solidly researched book, “Unprecedented Crime: Climate Science Denial and Game Changers for Survival.”

Dr. James E. Hansen, former chief NASA climate scientist, says in his Foreword that the book makes “an overwhelming case that the public, especially young people, are victims of 'Unprecedented Crime.'"

Fortunately, he adds, the book also points to technological game changers that could alleviate the consequences for current and future generations.

Co-author Dr. Peter Carter, a physician, is founder of the Climate Emergency Institute and an expert reviewer for the Intergovernmental on Climate Change. He lectures worldwide on the climate emergency that Hansen first warned Congress about in 1988.

Co-author Elizabeth Woodworth is a climate writer and activist who regularly attends UN climate summits to introduce new books on global energy solutions that – because they rival fossil fuels – remain unreported in the North American corporate media.

From the Introduction:

“This book takes an unusual approach to the entrenched failure of governments and the media to act decisively and effectively to drastically curb CO2 emissions.

The fact that no emergency response has been mounted by national governments is a crime against humanity and indeed all of life.

To continue with business-as-usual at this late date is to knowingly, and therefore deliberately, compound this crime.”

An entire chapter, “Science Betrayed: The Crime of Denial,” referring to the “vertical integrated influence-peddling apparatus” of the Koch brothers, explores and documents the rampant, ongoing funding of science denial that has seduced and corrupted virtually the entire Republican establishment in Washington, DC.

Reinhold Gallmetzer, an Appeals Counsel at the International Criminal Court, notes that “Peter Carter and Elizabeth Woodworth’s book is a timely and important contribution to the debate regarding how criminal prosecutions, both at the national and international level, could be used to repress and deter climate damaging conduct at a large scale and on a lasting basis.”

If anyone is in doubt about the science itself, Dr. Carter has produced a reader-friendly Science Appendix, full of graphs and images from NASA and NOAA that leave no doubt as to the urgency of the developing catastrophe. It is simply a matter of facing the truth and taking action.

Meanwhile, the hundreds of game changers presented in this book wait in the wings for strong leadership to take the helm and guide civilization to safety.

Contact: Clarity Press
Review copies: businessmanager@claritypress.com
Author interviews: Dr. Peter Carter, 250-629-3811; UnprecedentedCrime@gmail.com

Business Manager
Clarity Press
404-647-6501
email us here

Coal 101: What’s Wrong with Coal?


Source: EIN Presswire

Gene Synthesis Market 2018 Global Trend, Segmentation and Opportunities Forecast To 2023

Gene Synthesis -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2023

PUNE, MAHARASHTRA, INDIA, February 1, 2018 /EINPresswire.com/ — Gene Synthesis Industry

Description

Wiseguyreports.Com Adds “Gene Synthesis -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2023” To Its Research Database

Gene synthesis refers to chemically synthesizing a strand of DNA base-by-base. Unlike DNA replication that occurs in cells or by Polymerase Chain Reaction (PCR), gene synthesis does not require a template strand. Rather, gene synthesis involves the step-wise addition of nucleotides to a single-stranded molecule, which then serves as a template for creation of a complementary strand. Gene synthesis is the fundamental technology upon which the field of synthetic biology has been built. 

The global Gene Synthesis market will reach xxx Million USD in 2017. 99Strategy said Commercial dominates the largest Application share in 2017. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Gene Synthesis by Gene Length, region and Application, in addition, this report introduces market competition situation among the companys and company profile, besides, market price analysis and value chain features are covered in this report. 

Vendors Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.): 

Genescript 
GeneArt (Thermofischer) 
IDT 
DNA 2.0 (ATUM) 
OriGene 
BBI 
Genewiz 
Eurofins Genomics 
Gene Oracle 
SBS Genetech 
Bio Basic 

Request for Sample Report @ https://www.wiseguyreports.com/sample-request/2209552-global-gene-synthesis-market-analysis-2012-2017-and-forecast-2018-2023

Product Type Coverage (Market Size & Forecast, Major Vendors of Gene Length etc.): 
By Gene Length 
Below 1200 bp 
1201-3000 bp 
3001-5000 bp 
Above 5000 bp 

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.): 
Commercial 
Academic Research 

Region Coverage (Regional Output, Demand & Forecast by Countries etc.): 
North America (USA, Canada, Mexico) 
Europe (Germany, UK, France, Italy, Russia, etc.) 
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, etc.) 
South America (Brazil, Argentina, Columbia, etc) 
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, etc.)

Leave a Query @ https://www.wiseguyreports.com/enquiry/2209552-global-gene-synthesis-market-analysis-2012-2017-and-forecast-2018-2023

Table of Content 

1 Industry Overview 
1.1 Gene Synthesis Industry 
1.1.1 Overview 
1.1.2 Development of Gene Synthesis 
1.2 Market Segment 
1.2.1 Upstream 
1.2.2 Downstream 
1.3 Cost Analysis 
2 Industry Environment 
2.1 Policy 
2.2 Economics 
2.3 Sociology 
2.4 Technology 
3 Gene Synthesis Market by Gene Length 
3.1 Segment Overview 
3.1.1 Below 1200 bp 
3.1.2 1201-3000 bp 
3.1.3 3001-5000 bp 
3.1.4 Above 5000 bp 
3.2 Market Size 
3.3 Market Forecast 
4 Major Companies List 
4.1 Genescript 
4.1.1 Company Overview 
4.1.2 Business Operation 
4.2 GeneArt (Thermofischer) 
4.2.1 Company Overview 
4.2.2 Business Operation 
4.3 IDT 
4.3.1 Company Overview 
4.3.2 Business Operation 
4.4 DNA 2.0 (ATUM) 
4.4.1 Company Overview 
4.4.2 Business Operation 
4.5 OriGene 
4.5.1 Company Overview 
4.5.2 Business Operation 
4.6 BBI 
4.6.1 Company Overview 
4.6.2 Business Operation 
4.7 Genewiz 
4.7.1 Company Overview 
4.7.2 Business Operation 
4.8 Eurofins Genomics 
4.8.1 Company Overview 
4.8.2 Business Operation 
4.9 Gene Oracle 
4.9.1 Company Overview 
4.9.2 Business Operation 
4.10 SBS Genetech 
4.10.1 Company Overview 
4.10.2 Business Operation 
4.11 Bio Basic 
5 Market Competition 
5.1 Vendors Competition 
5.2 Regional Concentration 
6 Market Demand 
6.1 Demand Situation 
6.1.1 Demand in Commercial 
6.1.2 Demand in Academic Research 
6.2 Regional Demand Comparison 
6.3 Demand Forecast 
7 Region Operation 
7.1 Regional Output 
7.2 Regional Demand 
7.2.1 North America 
7.2.1.1 Overview 
7.2.1.2 by Country 
7.2.2 Europe 
7.2.2.1 Overview 
7.2.2.2 by Country 
7.2.3 Asia-Pacific 
7.2.3.1 Overview 
7.2.3.2 by Country 
7.2.4 South America 
7.2.4.1 Overview 
7.2.4.2 by Country 
7.2.5 Middle East & Africa 
7.2.5.1 Overview 
7.2.5.2 by Country 
7.3 Regional Forecast 
8 Marketing & Price 
8.1 Price and Margin 
8.1.1 Price Trends 
8.1.2 Factors of Price Change 
8.1.3 Manufacturers Gross Margin Analysis 
8.2 Value Chain 
8.3 Marketing Channel 
9 Research Conclusion 

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=2209552

Continued…                       

Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (Us)  Ph: +44 208 133 9349 (Uk)

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Non-PVC IV Bag Market 2018 Global Trend, Segmentation and Opportunities Forecast To 2023

Non-PVC IV Bag -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2023

PUNE, MAHARASHTRA, INDIA, February 1, 2018 /EINPresswire.com/ — Non-PVC IV Bag Industry

Description

Wiseguyreports.Com Adds “Non-PVC IV Bag -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2023” To Its Research Database

The global Non-PVC IV Bag market will reach Volume Million USD in 2017 and CAGR xx% 2011-2017. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Non-PVC IV Bag by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.): 

Fresenius Kabi 
Baxter 
B.Braun 
Hospira 
Technoflex 
Renolit 
Otsuka 
Sippex 
Pharmaceutical Solutions 
Vioser 
ICU Medical 
Well Pharma

Request for Sample Report @ https://www.wiseguyreports.com/sample-request/2209575-global-non-pvc-iv-bag-market-analysis-2011-2017-and-forecast-2018-2023

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.): 
Flex Plastic 
Semi-rigid IV Bags 
Glass Bottles

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.): 
Hospital 
Clinic

Region Coverage (Regional Output, Demand & Forecast by Countries etc.): 
North America 
Europe 
Asia-Pacific 
South America 
Middle East & Africa

Leave a Query @ https://www.wiseguyreports.com/enquiry/2209575-global-non-pvc-iv-bag-market-analysis-2011-2017-and-forecast-2018-2023

Table of Content 

1 Industry Overview 
1.1 Non-PVC IV Bag Industry 
1.1.1 Overview 
1.1.2 Development of Non-PVC IV Bag

1.2 Market Segment 
1.2.1 Upstream 
1.2.2 Downstream 
1.3 Cost Analysis

2 Industry Environment 
2.1 Policy 
2.2 Economics 
2.3 Sociology 
2.4 Technology

3 Non-PVC IV Bag Market by Type 
3.1 Segment Overview 
3.1.1 Flex Plastic 
3.1.2 Semi-rigid IV Bags 
3.1.3 Glass Bottles

3.2 Market Size 
3.3 Market Forecast

4 Major Companies List 
4.1 Fresenius Kabi (Company Profile, Sales Data etc.) 
4.2 Baxter (Company Profile, Sales Data etc.) 
4.3 B.Braun (Company Profile, Sales Data etc.) 
4.4 Hospira (Company Profile, Sales Data etc.) 
4.5 Technoflex (Company Profile, Sales Data etc.) 
4.6 Renolit (Company Profile, Sales Data etc.) 
4.7 Otsuka (Company Profile, Sales Data etc.) 
4.8 Sippex (Company Profile, Sales Data etc.) 
4.9 Pharmaceutical Solutions (Company Profile, Sales Data etc.) 
4.10 Vioser (Company Profile, Sales Data etc.) 
4.11 ICU Medical (Company Profile, Sales Data etc.) 
4.12 Well Pharma (Company Profile, Sales Data etc.)

5 Market Competition 
5.1 Company Competition 
5.2 Regional Market by Company

6 Market Demand 
6.1 Demand Situation 
6.1.1 Demand in Hospital 
6.1.2 Demand in Clinic

6.2 Regional Demand Comparison 
6.3 Demand Forecast

7 Region Operation 
7.1 Regional Output 
7.2 Regional Market 
7.3 by Region 
7.3.1 North America 
7.3.1.1 Overview 
7.3.1.2 by Country (U.S., Canada, Mexico) 
7.3.2 Europe 
7.3.2.1 Overview 
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.) 
7.3.3 Asia-Pacific 
7.3.3.1 Overview 
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.) 
7.3.4 South America 
7.3.4.1 Overview 
7.3.4.2 by Country (Brazil, Argentina etc.) 
7.3.5 Middle East & Africa 
7.3.5.1 Overview 
7.3.5.2 by Country (Saudi Arabia, South Africa etc.) 
7.4 Regional Forecast

8 Marketing & Price 
8.1 Price and Margin 
8.1.1 Price Trends 
8.1.2 Factors of Price Change 
8.1.3 Manufacturers Gross Margin Analysis 
8.2 Value Chain 
8.3 Marketing Channel

9 Research Conclusion

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=2209575

Continued…                       

Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (Us)  Ph: +44 208 133 9349 (Uk)

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Dental Drugs Market 2018 Global Trend, Segmentation and Opportunities Forecast To 2023

Dental Drugs -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2023

PUNE, MAHARASHTRA, INDIA, February 1, 2018 /EINPresswire.com/ — Dental Drugs Industry

Description

Wiseguyreports.Com Adds “Dental Drugs -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2023” To Its Research Database

There are a number of different drugs that dentist may prescribe, depending on patient’s condition. Some medications are prescribed to fight certain oral diseases, to prevent or treat infections, or to control pain and relieve anxiety. The dose of the drugs and instructions on how to take them will differ from patient to patient, depending on what the drug is being used for, patient's age, weight, and other considerations. 

The global Dental Drugs market will reach xxx Million USD in 2017. 99Strategy said Hospitals dominates the largest Channel share in 2017. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Dental Drugs by Type, region and Channel, in addition, this report introduces market competition situation among the companys and company profile, besides, market price analysis and value chain features are covered in this report. 

Vendors Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.): 

Merck 
Bayer 
J&J 
GSK 
3M 
Sunstar 
Colgate-Palmolive 
DenMat 
Showa Yakuhin Kako 
Valeant Pharmaceuticals 
Septodont 
Roche 
Hutchison China MediTech 
Xiuzheng Pharmaceutical 
Acteon 
Xttrium Laboratorie 
Mediwin Pharmaceuticals 

Request for Sample Report @ https://www.wiseguyreports.com/sample-request/2209547-global-dental-drugs-market-analysis-2012-2017-and-forecast-2018-2023

Product Type Coverage (Market Size & Forecast, Major Vendors of Type etc.): 
By Type 
OTC 
Prescription Drug 

Channel Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.): 
Hospitals 
Dental Clinics 
Drugstores 

Region Coverage (Regional Output, Demand & Forecast by Countries etc.): 
North America (USA, Canada, Mexico) 
Europe (Germany, UK, France, Italy, Russia, etc.) 
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, etc.) 
South America (Brazil, Argentina, Columbia, etc) 
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, etc.)

Leave a Query @ https://www.wiseguyreports.com/enquiry/2209547-global-dental-drugs-market-analysis-2012-2017-and-forecast-2018-2023

Table of Content 

1 Industry Overview 
1.1 Dental Drugs Industry 
1.1.1 Overview 
1.1.2 Development of Dental Drugs 
1.2 Market Segment 
1.2.1 Upstream 
1.2.2 Downstream 
1.3 Cost Analysis 
2 Industry Environment 
2.1 Policy 
2.2 Economics 
2.3 Sociology 
2.4 Technology 
3 Dental Drugs Market by Type 
3.1 Segment Overview 
3.1.1 OTC 
3.1.2 Prescription Drug 
3.2 Market Size 
3.3 Market Forecast 
4 Major Companies List 
4.1 Merck 
4.1.1 Company Overview 
4.1.2 Business Operation 
4.2 Bayer 
4.2.1 Company Overview 
4.2.2 Business Operation 
4.3 J&J 
4.3.1 Company Overview 
4.3.2 Business Operation 
4.4 GSK 
4.4.1 Company Overview 
4.4.2 Business Operation 
4.5 3M 
4.5.1 Company Overview 
4.5.2 Business Operation 
4.6 Sunstar 
4.6.1 Company Overview 
4.6.2 Business Operation 
4.7 Colgate-Palmolive 
4.7.1 Company Overview 
4.7.2 Business Operation 
4.8 DenMat 
4.8.1 Company Overview 
4.8.2 Business Operation 
4.9 Showa Yakuhin Kako 
4.9.1 Company Overview 
4.9.2 Business Operation 
4.10 Valeant Pharmaceuticals 
4.10.1 Company Overview 
4.10.2 Business Operation 
4.11 Septodont 
4.12 Roche 
4.13 Hutchison China MediTech 
4.14 Xiuzheng Pharmaceutical 
4.15 Acteon 
4.16 Xttrium Laboratorie 
4.17 Mediwin Pharmaceuticals 
5 Market Competition 
5.1 Vendors Competition 
5.2 Regional Concentration 
6 Market Demand 
6.1 Demand Situation 
6.1.1 Demand in Hospitals 
6.1.2 Demand in Dental Clinics 
6.1.3 Demand in Drugstores 
6.2 Regional Demand Comparison 
6.3 Demand Forecast 
7 Region Operation 
7.1 Regional Output 
7.2 Regional Demand 
7.2.1 North America 
7.2.1.1 Overview 
7.2.1.2 by Country 
7.2.2 Europe 
7.2.2.1 Overview 
7.2.2.2 by Country 
7.2.3 Asia-Pacific 
7.2.3.1 Overview 
7.2.3.2 by Country 
7.2.4 South America 
7.2.4.1 Overview 
7.2.4.2 by Country 
7.2.5 Middle East & Africa 
7.2.5.1 Overview 
7.2.5.2 by Country 
7.3 Regional Forecast 
8 Marketing & Price 
8.1 Price and Margin 
8.1.1 Price Trends 
8.1.2 Factors of Price Change 
8.1.3 Manufacturers Gross Margin Analysis 
8.2 Value Chain 
8.3 Marketing Channel 
9 Research Conclusion 

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=2209547

Continued…           

Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (Us)  Ph: +44 208 133 9349 (Uk)

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Animal Plasma and Derivatives Market 2018 Global Industry Key Players, Share, Trend, Segmentation and Forecast to 2025

Animal Plasma and Derivatives Market –Market Demand, Growth, Opportunities, Analysis of Top Key Players and Forecast to 2025

PUNE, INDIA, February 1, 2018 /EINPresswire.com/ — Animal Plasma and Derivatives Market 2018

Wiseguyreports.Com adds “Animal Plasma and Derivatives Market –Market Demand, Growth, Opportunities, Analysis of Top Key Players and Forecast to 2025” To Its Research Database.

Report Details:

This report provides in depth study of “Animal Plasma and Derivatives Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Animal Plasma and Derivatives Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

This report studies Animal Plasma and Derivatives in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering 
Proliant Inc. 
Thermo Fisher Scientific, Inc. 
Merck KGaA 
Kraeber & Co GmbH 
LAMPIRE Biological Laboratories, Inc. 
Lake Immunogenics, Inc. 
Rocky Mountain Biologicals Inc. 
ANZCO Foods Ltd. 
Auckland BioSciences Ltd. 
Bovogen Biologicals Pty Ltd.

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/2751636-global-animal-plasma-and-derivatives-market-professional-survey-report-2018

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into 
By Derivatives Type 
Immunoglobulin 
Fibrinogen 
Serum Albumin 
Fetal Bovine Serum 
Thrombin 
New Born Calf Serum 
By Animal Type 
Bovine 
Ovine 
Others

By Application, the market can be split into 
Food & Beverages 
Pharmaceuticals 
Cosmetics 
Feed 
Others

By Regions, this report covers (we can add the regions/countries as you want) 
North America 
China 
Europe 
Southeast Asia 
Japan 
India

If you have any special requirements, please let us know and we will offer you the report as you want.

Complete Report Details@ https://www.wiseguyreports.com/reports/2751636-global-animal-plasma-and-derivatives-market-professional-survey-report-2018

Major Key Points in Table of Content:

1 Industry Overview of Animal Plasma and Derivatives 
1.1 Definition and Specifications of Animal Plasma and Derivatives 
1.1.1 Definition of Animal Plasma and Derivatives 
1.1.2 Specifications of Animal Plasma and Derivatives 
1.2 Classification of Animal Plasma and Derivatives 
1.2.1 Immunoglobulin 
1.2.2 Fibrinogen 
1.2.3 Serum Albumin 
1.2.4 Fetal Bovine Serum 
1.2.5 Thrombin 
1.2.6 New Born Calf Serum 
1.3 Applications of Animal Plasma and Derivatives 
1.3.1 Food & Beverages 
1.3.2 Pharmaceuticals 
1.3.3 Cosmetics 
1.3.4 Feed 
1.3.5 Others 
1.4 Market Segment by Regions 
1.4.1 North America 
1.4.2 China 
1.4.3 Europe 
1.4.4 Southeast Asia 
1.4.5 Japan 
1.4.6 India

2 Manufacturing Cost Structure Analysis of Animal Plasma and Derivatives 
2.1 Raw Material and Suppliers 
2.2 Manufacturing Cost Structure Analysis of Animal Plasma and Derivatives 
2.3 Manufacturing Process Analysis of Animal Plasma and Derivatives 
2.4 Industry Chain Structure of Animal Plasma and Derivatives

8 Major Manufacturers Analysis of Animal Plasma and Derivatives 
8.1 Proliant Inc. 
8.1.1 Company Profile 
8.1.2 Product Picture and Specifications 
8.1.2.1 Product A 
8.1.2.2 Product B 
8.1.3 Proliant Inc. 2016 Animal Plasma and Derivatives Sales, Ex-factory Price, Revenue, Gross Margin Analysis 
8.1.4 Proliant Inc. 2016 Animal Plasma and Derivatives Business Region Distribution Analysis 
8.2 Thermo Fisher Scientific, Inc. 
8.2.1 Company Profile 
8.2.2 Product Picture and Specifications 
8.2.2.1 Product A 
8.2.2.2 Product B 
8.2.3 Thermo Fisher Scientific, Inc. 2016 Animal Plasma and Derivatives Sales, Ex-factory Price, Revenue, Gross Margin Analysis 
8.2.4 Thermo Fisher Scientific, Inc. 2016 Animal Plasma and Derivatives Business Region Distribution Analysis 
8.3 Merck KGaA 
8.3.1 Company Profile 
8.3.2 Product Picture and Specifications 
8.3.2.1 Product A 
8.3.2.2 Product B 
8.3.3 Merck KGaA 2016 Animal Plasma and Derivatives Sales, Ex-factory Price, Revenue, Gross Margin Analysis 
8.3.4 Merck KGaA 2016 Animal Plasma and Derivatives Business Region Distribution Analysis 
8.4 Kraeber & Co GmbH 
8.4.1 Company Profile 
8.4.2 Product Picture and Specifications 
8.4.2.1 Product A 
8.4.2.2 Product B 
8.4.3 Kraeber & Co GmbH 2016 Animal Plasma and Derivatives Sales, Ex-factory Price, Revenue, Gross Margin Analysis 
8.4.4 Kraeber & Co GmbH 2016 Animal Plasma and Derivatives Business Region Distribution Analysis 
8.5 LAMPIRE Biological Laboratories, Inc. 
8.5.1 Company Profile 
8.5.2 Product Picture and Specifications 
8.5.2.1 Product A 
8.5.2.2 Product B 
8.5.3 LAMPIRE Biological Laboratories, Inc. 2016 Animal Plasma and Derivatives Sales, Ex-factory Price, Revenue, Gross Margin Analysis 
8.5.4 LAMPIRE Biological Laboratories, Inc. 2016 Animal Plasma and Derivatives Business Region Distribution Analysis 
8.6 Lake Immunogenics, Inc. 
8.6.1 Company Profile 
8.6.2 Product Picture and Specifications 
8.6.2.1 Product A 
8.6.2.2 Product B 
8.6.3 Lake Immunogenics, Inc. 2016 Animal Plasma and Derivatives Sales, Ex-factory Price, Revenue, Gross Margin Analysis 
8.6.4 Lake Immunogenics, Inc. 2016 Animal Plasma and Derivatives Business Region Distribution Analysis 
8.7 Rocky Mountain Biologicals Inc. 
8.7.1 Company Profile 
8.7.2 Product Picture and Specifications 
8.7.2.1 Product A 
8.7.2.2 Product B 
8.7.3 Rocky Mountain Biologicals Inc. 2016 Animal Plasma and Derivatives Sales, Ex-factory Price, Revenue, Gross Margin Analysis 
8.7.4 Rocky Mountain Biologicals Inc. 2016 Animal Plasma and Derivatives Business Region Distribution Analysis 
8.8 ANZCO Foods Ltd. 
8.8.1 Company Profile 
8.8.2 Product Picture and Specifications 
8.8.2.1 Product A 
8.8.2.2 Product B 
8.8.3 ANZCO Foods Ltd. 2016 Animal Plasma and Derivatives Sales, Ex-factory Price, Revenue, Gross Margin Analysis 
8.8.4 ANZCO Foods Ltd. 2016 Animal Plasma and Derivatives Business Region Distribution Analysis 
8.9 Auckland BioSciences Ltd. 
8.9.1 Company Profile 
8.9.2 Product Picture and Specifications 
8.9.2.1 Product A 
8.9.2.2 Product B 
8.9.3 Auckland BioSciences Ltd. 2016 Animal Plasma and Derivatives Sales, Ex-factory Price, Revenue, Gross Margin Analysis 
8.9.4 Auckland BioSciences Ltd. 2016 Animal Plasma and Derivatives Business Region Distribution Analysis 
8.10 Bovogen Biologicals Pty Ltd. 
8.10.1 Company Profile 
8.10.2 Product Picture and Specifications 
8.10.2.1 Product A 
8.10.2.2 Product B 
8.10.3 Bovogen Biologicals Pty Ltd. 2016 Animal Plasma and Derivatives Sales, Ex-factory Price, Revenue, Gross Margin Analysis 
8.10.4 Bovogen Biologicals Pty Ltd. 2016 Animal Plasma and Derivatives Business Region Distribution Analysis

Continued….

Buy now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=2751636

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire